Filing Details
- Accession Number:
- 0001012975-10-000362
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-12 19:17:04
- Reporting Period:
- 2010-10-08
- Filing Date:
- 2010-10-12
- Accepted Time:
- 2010-10-12 19:17:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
858803 | Avanir Pharmaceuticals Inc. | AVNR | Pharmaceutical Preparations (2834) | 330314804 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1166285 | Michael Steinmetz | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1249153 | Dennis Henner | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1252522 | Nicholas Galakatos | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1252523 | Robert Liptak | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1252525 | Kurt Wheeler | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1431403 | Nicholas Simon | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1431441 | Clarus Ventures I, Llc | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1431442 | Clarus Ventures I Gp, L.p. | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No | |
1431445 | Clarus Lifesciences I, L.p. | C/O Clarus Ventures, Llc 101 Main Street, Suite 1210 Cambridge MA 02142 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-10-08 | 240,838 | $3.47 | 15,151,480 | No | 4 | S | Indirect | By Fund |
Common Stock | Disposition | 2010-10-11 | 311,000 | $3.52 | 14,840,480 | No | 4 | S | Indirect | By Fund |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Fund |
No | 4 | S | Indirect | By Fund |
Footnotes
- Securities held of record by Clarus Lifesciences I, L.P. (the "Fund"). Clarus Ventures I GP, L.P. (the "GPLP"), controls the general partner of the Fund and may be deemed to beneficially own certain of the shares held of record by the Fund. The GPLP disclaims beneficial ownership of all shares held of record by the Fund in which the GPLP does not have an actual pecuniary interest. Clarus Ventures I, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by the Fund. Each of Messrs. Galakatos, Henner, Liptak, Simon, Steinmetz and Wheeler, as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by the Fund. Each of the GPLLC and Messrs. Galakatos, Henner, Liptak, Simon, Steinmetz and Wheeler disclaims beneficial ownership of all shares held of record by the Fund in which he does not have an actual pecuniary interest.